Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Artiva Biotherapeutics (ARTV) FCF Margin (2023 - 2024)

Artiva Biotherapeutics (ARTV) has disclosed FCF Margin for 2 consecutive years, with 6015.54% as the latest value for Q1 2024.

  • On a quarterly basis, FCF Margin changed N/A to 6015.54% in Q1 2024 year-over-year; TTM through Dec 2024 was 21947.81%, a N/A change, with the full-year FY2024 number at 21947.81%, down 2180369.0% from a year prior.
  • FCF Margin was 6015.54% for Q1 2024 at Artiva Biotherapeutics, down from 565.75% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 42.39% in Q3 2023 to a low of 6015.54% in Q1 2024.